sodium acetate · Hospira · NDA 018893
Sodium Acetate
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220274, Dr Reddys · 018893-001Approved 17 Apr 2026Detected 25 Oct 2026Historical import
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 018893 · 001 · RLD | solution, intravenous | 40MEQ/20ML (2MEQ/ML) | open |
| 018893 · 002 · RLD | solution, intravenous | 100MEQ/50ML (2MEQ/ML) | open |
| 018893 · 003 · RLD | solution, intravenous | 200MEQ/100ML (2MEQ/ML) | open |